Heat shock protein 60 reactive T cells in juvenile idiopathic arthritis: what is new?
暂无分享,去创建一个
[1] E. Benarroch. Heat shock proteins , 2011, Neurology.
[2] A. Liston,et al. Regulatory T Cells , 2011, Methods in Molecular Biology.
[3] Hannu Kautiainen,et al. Arthritis Research & Therapy , 2009 .
[4] S. Zheng,et al. Natural and TGF-beta-induced Foxp3(+)CD4(+) CD25(+) regulatory T cells are not mirror images of each other. , 2008, Trends in immunology.
[5] D. Vignali,et al. How regulatory T cells work , 2008, Nature Reviews Immunology.
[6] I. Cohen,et al. Immunological efficacy of heat shock protein 60 peptide DiaPep277TM therapy in clinical type I diabetes , 2008, Clinical and experimental immunology.
[7] T. Nomura,et al. Regulatory T Cells and Immune Tolerance , 2008, Cell.
[8] L. Wagner-Weiner. Pediatric Rheumatology for the Adult Rheumatologist , 2008, Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases.
[9] W. van Eden,et al. Autoantigen-Specific IL-10-Transduced T Cells Suppress Chronic Arthritis by Promoting the Endogenous Regulatory IL-10 Response1 , 2008, The Journal of Immunology.
[10] K. Mills,et al. TLR ligand suppression or enhancement of Treg cells? A double-edged sword in immunity to tumours , 2008, Oncogene.
[11] Charles Schmidt. Clinical setbacks for toll-like receptor 9 agonists in cancer , 2007, Nature Biotechnology.
[12] A. Sette,et al. Differential recognition of heat-shock protein dnaJ-derived epitopes by effector and Treg cells leads to modulation of inflammation in juvenile idiopathic arthritis. , 2007, Arthritis and rheumatism.
[13] I. Cohen,et al. Therapy with the hsp60 peptide DiaPep277™ in C‐peptide positive type 1 diabetes patients , 2007, Diabetes/metabolism research and reviews.
[14] J. Bluestone,et al. Adaptive TGF-β-dependent regulatory T cells control autoimmune diabetes and are a privileged target of anti-CD3 antibody treatment , 2007, Proceedings of the National Academy of Sciences.
[15] Irun R Cohen,et al. Newborn humans manifest autoantibodies to defined self molecules detected by antigen microarray informatics. , 2007, The Journal of clinical investigation.
[16] Bernhard Fleischer,et al. Synergistic and Differential Modulation of Immune Responses by Hsp60 and Lipopolysaccharide* , 2007, Journal of Biological Chemistry.
[17] T. Huizinga,et al. Transient expression of FOXP3 in human activated nonregulatory CD4+ T cells , 2007, European journal of immunology.
[18] E. Hoppenreijs,et al. Blood and synovial fluid cytokine signatures in patients with juvenile idiopathic arthritis: a cross-sectional study , 2006, Annals of the rheumatic diseases.
[19] Christopher H Contag,et al. Early CD30 signaling is critical for adoptively transferred CD4+CD25+ regulatory T cells in prevention of acute graft-versus-host disease. , 2006, Blood.
[20] Alberto Martini,et al. JUVENILE IDIOPATHIC ARTHRITIS , 2005, Archives of disease in childhood - Education & practice edition.
[21] I. Cohen,et al. Therapy with the hsp 60 peptide DiaPep 277 TM in C-peptide positive type 1 diabetes patients , 2007 .
[22] C. Contag,et al. Early CD 30 signaling is critical for adoptively transferred CD 4 CD 25 regulatory T cells in prevention of acute graft-versus-host disease , 2007 .
[23] S. Albani,et al. Modulation of T Cell Function by Combination of Epitope Specific and Low Dose Anticytokine Therapy Controls Autoimmune Arthritis , 2006, PloS one.
[24] R. Steinman,et al. Expansion of FOXP3high regulatory T cells by human dendritic cells (DCs) in vitro and after injection of cytokine-matured DCs in myeloma patients. , 2006, Blood.
[25] A. Akbar,et al. Human CD4+ CD25hi Foxp3+ regulatory T cells are derived by rapid turnover of memory populations in vivo , 2006 .
[26] Guy Tal,et al. Heat shock protein 60 enhances CD4+ CD25+ regulatory T cell function via innate TLR2 signaling. , 2006, The Journal of clinical investigation.
[27] L. Joosten,et al. Identification of Small Heat Shock Protein B8 (HSP22) as a Novel TLR4 Ligand and Potential Involvement in the Pathogenesis of Rheumatoid Arthritis1 , 2006, The Journal of Immunology.
[28] F. Liew,et al. Toll-like receptor 2 signaling modulates the functions of CD4+ CD25+ regulatory T cells. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[29] G. Panayi,et al. BiP regulates autoimmune inflammation and tissue damage. , 2006, Autoimmunity reviews.
[30] J. Dehoorne,et al. Effect of age on prevalence of anticitrullinated protein/peptide antibodies in polyarticular juvenile idiopathic arthritis. , 2006, Rheumatology.
[31] M. Mann,et al. Specificity in Toll-like receptor signalling through distinct effector functions of TRAF3 and TRAF6 , 2006, Nature.
[32] A. Shaw,et al. Triggering TLR signaling in vaccination. , 2006, Trends in immunology.
[33] G. Stoll,et al. Effective treatment of adjuvant arthritis with a stimulatory CD28-specific monoclonal antibody. , 2006, The Journal of rheumatology.
[34] A. Akbar,et al. Human CD4+ CD25hi Foxp3+ regulatory T cells are derived by rapid turnover of memory populations in vivo. , 2006, The Journal of clinical investigation.
[35] M. Levings,et al. Human CD4+ T Cells Express TLR5 and Its Ligand Flagellin Enhances the Suppressive Capacity and Expression of FOXP3 in CD4+CD25+ T Regulatory Cells1 , 2005, The Journal of Immunology.
[36] S. Albani,et al. Recent developments in immunomodulatory peptides in juvenile rheumatic diseases: from trigger to dimmer? , 2005, Current opinion in rheumatology.
[37] A. Sette,et al. Tolerogenic immune responses to novel T-cell epitopes from heat-shock protein 60 in juvenile idiopathic arthritis , 2005, The Lancet.
[38] B. Prakken,et al. Heat-shock proteins induce T-cell regulation of chronic inflammation , 2005, Nature Reviews Immunology.
[39] C. Gianfrani,et al. IL‐10‐Producing T Regulatory Type 1 Cells and Oral Tolerance , 2004, Annals of the New York Academy of Sciences.
[40] Irun R Cohen,et al. Inhibition of adjuvant-induced arthritis by DNA vaccination with the 70-kd or the 90-kd human heat-shock protein: immune cross-regulation with the 60-kd heat-shock protein. , 2004, Arthritis and rheumatism.
[41] T. Mak,et al. CD30/CD30 Ligand (CD153) Interaction Regulates CD4+ T Cell-Mediated Graft-versus-Host Disease1 , 2004, The Journal of Immunology.
[42] M. Tsan,et al. Heat shock protein and innate immunity. , 2004, Cellular & molecular immunology.
[43] W. Kuis,et al. CD4+CD25bright Regulatory T Cells Actively Regulate Inflammation in the Joints of Patients with the Remitting Form of Juvenile Idiopathic Arthritis , 2004, The Journal of Immunology.
[44] M. Suarez‐Almazor,et al. International League of Associations for Rheumatology: International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001 , 2004 .
[45] G. Tellides,et al. CD4+CD25+ regulatory T cells suppress allograft rejection mediated by memory CD8+ T cells via a CD30-dependent mechanism. , 2004, The Journal of clinical investigation.
[46] D. Adorno,et al. CD30 antigen: not a physiological marker for TH2 cells but an important costimulator molecule in the regulation of the balance between TH1/TH2 response. , 2003, Transplant immunology.
[47] I. Cohen,et al. T cells respond to heat shock protein 60 via TLR2: activation of adhesion and inhibition of chemokine receptors , 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[48] Anna Chodos,et al. Antigen-dependent Proliferation of CD4+ CD25+ Regulatory T Cells In Vivo , 2003, The Journal of experimental medicine.
[49] S. Kamphuis,et al. The spontaneous remission of juvenile idiopathic arthritis is characterized by CD30+ T cells directed to human heat-shock protein 60 capable of producing the regulatory cytokine interleukin-10. , 2003, Arthritis and rheumatism.
[50] K. Asadullah,et al. Interleukin-10 Therapy—Review of a New Approach , 2003, Pharmacological Reviews.
[51] A. Mowat,et al. Anatomical basis of tolerance and immunity to intestinal antigens , 2003, Nature Reviews Immunology.
[52] I. Caramalho,et al. Regulatory T Cells Selectively Express Toll-like Receptors and Are Activated by Lipopolysaccharide , 2003, The Journal of experimental medicine.
[53] R. Jack,et al. Macrophages as main inducers of IFN-gamma in T cells following administration of human and mouse heat shock protein 60. , 2002, International immunology.
[54] W. van Eden,et al. Inhibition of adjuvant-induced arthritis by interleukin-10-driven regulatory cells induced via nasal administration of a peptide analog of an arthritis-related heat-shock protein 60 T cell epitope. , 2002, Arthritis and rheumatism.
[55] Carsten J. Kirschning,et al. Endocytosed HSP60s Use Toll-like Receptor 2 (TLR2) and TLR4 to Activate the Toll/Interleukin-1 Receptor Signaling Pathway in Innate Immune Cells* , 2001, The Journal of Biological Chemistry.
[56] F. Schumann,et al. The stress protein BiP is overexpressed and is a major B and T cell target in rheumatoid arthritis. , 2001, Arthritis and rheumatism.
[57] G. Pizzolo,et al. Role of CD30+ T cells in rheumatoid arthritis: a counter-regulatory paradigm for Th1-driven diseases. , 2001, Trends in immunology.
[58] M. Roncarolo,et al. Differentiation of T Regulatory Cells by Immature Dendritic Cells , 2001, The Journal of experimental medicine.
[59] H. Ochs,et al. The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3 , 2001, Nature Genetics.
[60] A Sette,et al. Tools of the Trade in Vaccine Design , 2000, Science.
[61] H. Weiner,et al. Oral tolerance, an active immunologic process mediated by multiple mechanisms. , 2000, The Journal of clinical investigation.
[62] Mahavir Singh,et al. A Conserved Mycobacterial Heat Shock Protein (hsp) 70 Sequence Prevents Adjuvant Arthritis upon Nasal Administration and Induces IL-10-Producing T Cells That Cross-React with the Mammalian Self-hsp70 Homologue1 , 2000, The Journal of Immunology.
[63] H. Kolb,et al. Cutting Edge: Heat Shock Protein 60 Is a Putative Endogenous Ligand of the Toll-Like Receptor-4 Complex1 , 2000, The Journal of Immunology.
[64] Y. Yoshikai,et al. Activation of T cells recognizing an epitope of heat-shock protein 70 can protect against rat adjuvant arthritis. , 1999, Journal of immunology.
[65] F. Breedveld,et al. Analysis of serial synovial biopsies in patients with rheumatoid arthritis: description of a control group without clinical improvement after treatment with interleukin 10 or placebo. , 1999, The Journal of rheumatology.
[66] J. Goodall,et al. T cell responses to heat-shock protein 60: differential responses by CD4+ T cell subsets according to their expression of CD45 isotypes. , 1999, Journal of immunology.
[67] W. Kuis,et al. Autoreactivity to human heat-shock protein 60 predicts disease remission in oligoarticular juvenile rheumatoid arthritis. , 1996, Arthritis and rheumatism.
[68] C. Morris,et al. A synthetic 10‐kD heat shock protein (hsp10) from Mycobacterium tuberculosis modulates adjuvant arthritis , 1996, Clinical and experimental immunology.
[69] P. Helders,et al. Juvenile chronic arthritis: T cell reactivity to human HSP60 in patients with a favorable course of arthritis. , 1995, The Journal of clinical investigation.
[70] W. van Eden,et al. Activation of T cells recognizing self 60-kD heat shock protein can protect against experimental arthritis , 1995, The Journal of experimental medicine.
[71] R. Gupta,et al. Adjuvants for human vaccines--current status, problems and future prospects. , 1995, Vaccine.
[72] S. Albani,et al. Immune responses to the Escherichia coli dnaJ heat shock protein in juvenile rheumatoid arthritis and their correlation with disease activity. , 1994, The Journal of pediatrics.
[73] P. Matzinger. Tolerance, danger, and the extended family. , 1994, Annual review of immunology.
[74] E. Craig,et al. Heat shock proteins: molecular chaperones of protein biogenesis , 1993, Microbiological reviews.
[75] W. van Eden,et al. Two monoclonal antibodies generated against human hsp60 show reactivity with synovial membranes of patients with juvenile chronic arthritis , 1992, The Journal of experimental medicine.
[76] J. Bijlsma,et al. Recognition of human 60 kD heat shock protein by mononuclear cells from patients with juvenile chronic arthritis , 1991, The Lancet.
[77] I. Cohen,et al. Vaccination against autoimmune mouse diabetes with a T-cell epitope of the human 65-kDa heat shock protein. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[78] Ellis Rj. The molecular chaperone concept. , 1990 .
[79] R. Ellis,et al. The molecular chaperone concept. , 1989, Biochemical Society symposium.
[80] I. Cohen,et al. Cloning of the mycobacterial epitope recognized by T lymphocytes in adjuvant arthritis , 1988, Nature.